← Leaderboards
John R Mascola
Wits Health Consortium (Pty), Ltd
$218,615
Attributed
$874,460
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $174.9K · FY2015–19$200K$150K$100K$50K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$874,460 · 1
By mechanism
U01$874,460 · 1
Top collaborators
- Peter D Kwong5 shared
- Penny Moore5 shared
- Lynn Morris5 shared
Most similar at Wits Health Consortium (Pty), Ltd
Same institution · by research overlap
- Glenda E Gray$398,868,516
- Penny Moore$683,272
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1AnimalsGleanGrowthAntigensBaseGenesAntibodiesAntibody Binding SitesB-LymphocytesCell Culture TechniquesCell OntogenyCell SeparationCharacteristicsBase SequenceCohortCross-Sectional StudiesDesignEpitopesEventEvolutionExposure ToFutureHiv Antibodies
Grant awards (5)
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design$174,892
U01 · FY2019 · AI
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design$174,892
U01 · FY2018 · AI
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design$174,892
U01 · FY2017 · AI
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design$174,892
U01 · FY2016 · AI
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design$174,892
U01 · FY2015 · AI